Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
06/1999
06/16/1999EP0827507B1 Protease inhibiting succinic acid derivatives
06/16/1999CN1219841A DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
06/16/1999CN1219533A Sulfonamide-substituted fused 5-membered ring compounds, their use as medicament, and pharmaceutical preparation comprising them
06/16/1999CN1043651C Process for preparing purified indigo
06/16/1999CN1043642C Herbicidal pyrrolopyridine compounds, herbicidal composition containing same and use
06/15/1999US5912365 Derivatives of 2-azabicyclo 2.2.1! heptane, their preparation and their application
06/15/1999US5912308 Polyepoxides, epoxy resins, polycyanates and polytriazines
06/15/1999US5912260 Gastrin and CCK antagonists
06/15/1999US5911970 Antitumor agents and anticarcinogenic agents
06/15/1999CA2155664C Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as antiinflammatory agents
06/15/1999CA2119155C Fungicides for the control of take-all disease of plants
06/15/1999CA2006464C Process for the preparation of phenyl-1 diethylaminocarbonyl-1 phtaliminomethyl-2 cyclopropane 2
06/12/1999CA2224752A1 5-alkenyl and 5-alkynyl indole compounds
06/10/1999WO1999028304A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
06/10/1999WO1999028297A1 Substituted indoles, having a thrombin inhibiting effect
06/10/1999DE19753522A1 Substituierte Indole, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted indoles, their preparation and their use as medicaments
06/10/1999CA2312749A1 Pdgf receptor kinase inhibitory compounds and compositions, method for synthesis of same and use of same for treatment of proliferate disorders
06/09/1999EP0921119A1 Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
06/09/1999EP0921116A1 N-(4-carbamimido-phenyl)-glycine amide derivatives
06/09/1999EP0920424A1 Non-peptide bombesin receptor antagonists
06/09/1999EP0920416A1 Naphtholactams and lactones as bone morphogenetic protein active agents
06/09/1999EP0920411A1 Diagnostic imaging contrast agent with improved in-serum-relaxivity
06/09/1999EP0920306A2 Chemokine receptor antagonists and methods of use therefor
06/09/1999CN1219129A Use of substituted azaspirane in treatment of asthma
06/08/1999CA1340588C Amino acid derivatives
06/04/1999CA2255180A1 N-(4-carbamimido-phenyl)-phenylglycinamid derivatives
06/03/1999WO1999027356A1 Improvements in or relating to electrochemical assays
06/03/1999WO1999027020A1 Dibenzorhodamine dyes useful as flourescent labelling agents
06/03/1999WO1999026919A1 Biphenylamidine derivatives
06/03/1999WO1999026659A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
06/03/1999WO1999026624A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhe and scours
06/03/1999WO1999026611A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
06/03/1999WO1999005096A3 Urokinase inhibitors
06/03/1999WO1999002502A3 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
06/03/1999CA2311129A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scours
06/03/1999CA2310750A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
06/03/1999CA2310330A1 Biphenylamidine derivatives
06/03/1999CA2310069A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
06/02/1999EP0919998A1 Optical information recording medium
06/02/1999EP0919520A2 Fullernes substituted by several organic groups
06/02/1999EP0918781A1 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral ligands
06/02/1999EP0918761A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
06/02/1999EP0918752A2 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
06/02/1999EP0630376B1 Condensed indole derivatives as 5-ht4-receptor antagonists
06/02/1999EP0581939B1 N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors
06/02/1999CN1218474A Camptothecin-skeleton compounds isolated from mappia foetida and use thereof as syntones for medicaments as well as therapeutical agents
06/02/1999CN1218471A Carboline derivatives
06/02/1999CN1218467A Sulphur derivatives comprising amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
06/02/1999CN1218454A Preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
06/02/1999CN1218405A Treatment of cystic disease with TNF-'alpha'
06/02/1999CN1218044A Urea derivatives
06/02/1999CN1043509C Antioxidant cardioprotective use of and method of treatment using, hydroxycarbazole compounds
06/01/1999US5908937 Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoro propane derivatives
06/01/1999CA1340570C Process for synthesizing n-alkylated amino-acides and the esters thereof. their use for synthesizing carboxyalkyl dipeptides
06/01/1999CA1340567C Heterocyclic amide derivatives
05/1999
05/27/1999WO1999025686A1 Cyclic amine derivatives and their use as drugs
05/27/1999WO1999025684A1 Method of synthesis of pyrrole amides
05/27/1999WO1999025683A1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate
05/27/1999WO1999025340A1 Treatment for alzheimer's disease
05/27/1999CA2310319A1 2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
05/27/1999CA2310250A1 Treatment for alzheimer's disease
05/27/1999CA2310095A1 Method of synthesis of pyrrole amides
05/26/1999EP0918296A1 Method of virtual retrieval of analogs of lead compounds by constituting potential libraries
05/26/1999EP0918055A1 Process and intermediates for preparing 1-[9'H-carbazol-4'-yloxy]-3-[ 2''-(2'''- methoxy -phenoxy)-ethyl)-amino]-propan-2-ol[carvedilol]
05/26/1999EP0917529A1 Catalyst compositions and processes for olefin oligomerization and polymerization
05/26/1999EP0917462A1 Cell adhesion inhibitors
05/26/1999CN1217713A Sulphur derivatives with retroamide bond as endothelin-converting enzyme inhibitors
05/26/1999CN1217711A Aryl substituted cyclic amines as selective dopamine D3 ligands
05/20/1999WO1999024537A2 O-substituted n,n-diacylhydroxylamine bleach activators and compositions employing the same
05/20/1999WO1999024460A2 Dipeptide nitriles
05/20/1999WO1999024446A1 Metallocenes and catalysts for olefin-polymerisation
05/20/1999WO1999024407A1 Compounds which inhibit tryptase activity
05/20/1999WO1999024393A1 Process to produce oxazolidinones
05/20/1999WO1999024051A2 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear
05/20/1999WO1999024033A1 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
05/20/1999WO1999024026A2 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
05/20/1999WO1998022425A8 Method for preparing cyclopropylamines
05/20/1999CA2634657A1 Process to produce oxazolidinones
05/20/1999CA2309592A1 O-substituted n,n-diacylhydroxylamine bleach activators and compositions employing the same
05/20/1999CA2309117A1 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear
05/20/1999CA2308269A1 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
05/20/1999CA2304100A1 Process to produce oxazolidinones
05/20/1999CA2277127A1 Metallocenes and catalysts for olefin-polymerisation
05/19/1999EP0916646A2 Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
05/19/1999EP0916397A2 Apparatus and method used in multiple, simultaneous synthesis of general compounds
05/19/1999EP0915848A1 1,2-diarylindole as cox-2 inhibitors
05/19/1999EP0915847A1 Substituted sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
05/19/1999EP0915846A2 2- and 2,5-substituted phenylketoenols
05/19/1999EP0915837A1 Glyoxylic acid derivatives
05/19/1999EP0915829A1 Diagnostic imaging contrast agent with improved in-serum-relaxivity
05/19/1999CN1043405C Method for prepn. of pharmaceutical compositions contg. heterocyclic amide derivatives
05/18/1999CA2161284C Novel o-arylmethyl n-thioacyl hydroxylamines, processes for their preparation and pharmaceutical compositions containing them
05/14/1999WO1999023587A2 Method of virtual retrieval of analogs of lead compounds
05/14/1999WO1999023071A1 [indole]naphthopyrans, preparation, compositions and (co)polymer matrices containing them, synthesis intermediates
05/14/1999WO1999023070A1 N-acetylserotonin derivatives and uses thereof
05/14/1999WO1999007351A3 Indole derivatives and their use as mcp-1 antagonists
05/14/1999WO1999001423A8 Glucagon antagonists/inverse agonists
05/14/1999CA2306822A1 Method of virtual retrieval of analogs of lead compounds
05/14/1999CA2305753A1 ¬indole|naphthopyrans, preparation, compositions and (co)polymer matrices containing them, synthesis intermediates
05/14/1999CA2253164A1 Apparatus and method used in multiple, simultaneous synthesis of general compounds